Today’s AI Top Pick: FOUR

7/2/2026 · Short Squeeze High Growth screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Short Squeeze High GrowthFOURBUY NOW8.4 / 107/2/2026

Shift4 Payments (FOUR) is the cleanest setup in this pool: the fundamentals genuinely underwrite the squeeze thesis, and the multi-timeframe tape confirms it without forcing a chase. Valuation is the standout — fwdPE 7.23, PEG 0.49, PS 0.88 — paired with salesYoY of 28.28%, epsNextY of 21.67%, gross margin 27.74% and short float of 29.93%. The stock is down 49.63% over the past year and 21.87% YTD, so this is a screen-passing name that hasn't already run — pos_in_21bar_range on the weekly is 53.5% with a -16.22% drawdown from the recent high, meaning there's actual room to reprice rather than an extended chase. The forecast tape is aligned across the durations that matter: 1d fc_short +9.7%, fc_mid +43.34%, fc_long +47.65%; 1wk fc_mid +42.39%, fc_long +48.63%; 4h fc_long +15.32%. The only wobble is a 1h fc_short of -6.47%, which is exactly the kind of intraday softness that lets you get filled rather than a red flag. Kronos bullish_prob is 1.0 with near_term_bullish 0.8, and analyst recom is 2.28 with a 20% target upside — not a lonely trade, but not consensus-frothy either. News flow is supportive without being a hype spike: SeekingAlpha's July 1 'Poised To Win As The Experience Economy Continues To Expand' and the Russell Value index inclusion are catalysts, and Simply Wall St. explicitly frames the -50% drawdown as 'reasonable' valuation. Compare that to the higher-scored screener hits: CRK just had Goldman (PT $10, Sell) and Morgan Stanley (PT $16) cut targets against a $15.07 print — the fundamentals scream cheap but the analyst tape is actively deteriorating. CELH carries 'fully priced' and 'slowing core growth' headlines. UPST's wk fc_long of +134% is dazzling but it's pinned at 100% of range on three of four timeframes — that's the chase you're supposed to avoid. Today is the right entry because you have (a) a bullish multi-timeframe forecast stack, (b) mid-range positioning on the higher timeframes so you're not buying a blowoff, (c) a fundamentals block that would still be a buy without the squeeze setup, and (d) a positive catalyst backdrop. Waiting risks the 1d/1wk mid-horizon forecasts starting to unwind before you're in.

Entry zone

$47.50-$49.20 (buy into the 1h softness; scale-add on a dip toward the 4h -1.09% drawdown level near $48.50)

Stop loss

$44.00 (below the weekly drawdown structure; ~10% risk from entry)

First target

$56-58 (aligns with the 4h fc_long +15.3% and 1d fc_short +9.7%)

Longer target

$70-72 (1d fc_mid +43% / 1wk fc_mid +42% zone, and near the analyst 20% upside stack on a re-rate to ~10x fwdPE)

Risks

Short float of 29.93% cuts both ways — if the squeeze doesn't ignite, momentum sellers can press a name already down 49.6% YoY
1h fc_short of -6.47% and fc_long of -11.13% suggest near-term drift lower before the daily/weekly forecast plays out; early entries will be underwater first
Operating margin of only 9.99% and profit margin of 1.36% mean any payments-volume slowdown hits earnings disproportionately vs. the 21.67% epsNextY assumption
debtEq of 2.77 leaves less cushion if rates or credit spreads move against fintech names
Analyst recom of 2.28 is only moderate buy — not the strong-buy backstop you get from CRK (2.88 is actually worse) but well short of the 1.0-1.5 cluster in this pool

Honorable mentions

CELHHighest raw score (14) with bullish_prob 1.0, near_term 1.0, and 1d/1wk forecasts of +28%/+44% mid. Weekly pos_in_range 15.78% with -40% drawdown = deep-value setup on a name with 123% salesYoY. Held back to #2 by 'fully priced' and 'slowing core growth' headlines and PE of 76 vs. FOUR's fwdPE of 7.

UPSTScreener heavyweight — salesYoY 57.7%, epsNextY 103.4%, bullish_prob 1.0, 1wk fc_long +134.4%. Downgraded to #3 because it's at 100% of range on 1h/1d/1wk (buying the top), targetUpsidePct is only 9.7%, and profit margin is thin at 4.34%. BUY_PULLBACK, not BUY_NOW.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	FOUR	BUY NOW	8.4	fwdPE 7.23 + 1d/1wk forecasts +43%/+42% mid + weekly at 53% of range = confirmed setup without a chase.
2	CELH	BUY NOW	7.6	Screen-topper with 123% salesYoY and deep weekly drawdown (-40%), but PE 76 and 'slowing growth' headlines cap conviction.
3	UPST	BUY PULLBACK	7.2	Best forecast magnitude (1wk fc_long +134%) but pinned at range highs — wait for a pullback.
4	CRK	WAIT	6.0	Cheapest name in the pool (PE 6.94, PEG 0.37) but Goldman ($10 PT) and Morgan Stanley ($16 PT) just cut — analyst tape breaking down.
5	BIRK	BUY PULLBACK	5.7	Raymond James OW initiation with $52 PT, but mid-horizon forecasts are negative on 1h/4h/1d.
6	SYM	BUY PULLBACK	5.4	Near-term bullish 0.8 with 1d/1h fc_mid +20%/+11%, but weekly forecast is -25% and rich at 55x fwdPE.
7	PAR	BUY PULLBACK	5.0	Explosive 1d fc_mid +139% and fc_long +87% but 1h fc_long -34.6% flags a near-term unwind first.
8	PGY	WAIT	4.8	Strong fundamentals (PEG 0.22, epsNextY 40.6%) but 1h forecasts are -23% to -27% and 1d/1wk mid horizons are red.
9	DLO	WAIT	4.6	UBS upgrade + Russell inclusion is real, but bullish_prob 0 and 1d fc_mid -18.3% say wait.
10	DUOL	WAIT	4.4	1d/1wk fc_long +79%/+77% are compelling, but DA Davidson flagged DAU momentum stalling.
11	KLAR	WAIT	4.3	Google court win ($2B) is a positive, but no bullish_prob and mixed forecasts leave conviction low.
12	WGS	WAIT	4.2	PT hikes from Guggenheim/Piper are supportive, but fundamental_score -1.75 and 1h fc_long -37.7%.
13	SAIL	WAIT	4.0	Analyst-day catalyst and RBC AI positioning are constructive, but bullish_prob is null and no 1wk tape available.
14	XRX	WAIT	3.9	Weekly fc_mid +276% is an outlier from a broken name — ROE -117%, debtEq 8.67, targetUpside -11.3%.
15	STIM	WAIT	3.8	Weekly forecasts +131%/+141% and 220% analyst upside are eye-popping, but $94M cap and -152% ROE make it a lottery.
16	HROW	WAIT	3.5	Biosimilar launch is a real catalyst, but 1d fc_mid -12.7% and 1wk fc_mid -41.5% signal deteriorating tape.
17	NTST	AVOID	3.3	Every single forecast horizon on every timeframe is negative — screen pass but tape says no.
18	SNDX	WAIT	3.2	397% salesYoY but 1d/1wk fc_mid both -23% and -111.88% profit margin.
19	BETR	AVOID	3.0	Weekly fc_short -63% then +200% is noise, roe -611%, debtEq 83 — uninvestable fundamentals.
20	IBRX	AVOID	2.6	1d fc_short -45.5% and fc_long -66.9% completely overwhelm the retail bull narrative.
21	NTLA	AVOID	2.5	1d/4h forecasts -26% to -34% and operMargin -636% — the +23% pop already faded.
22	KULR	AVOID	2.5	ATM offering pause is a tell; profitMargin -383%, and 1d/4h forecasts sharply negative.
23	TGTX	AVOID	2.2	Every horizon deeply red: 1d fc_short -37%, 1wk fc_long -56.5%. Screen pass, tape rejection.
24	TEM	AVOID	2.1	CEO-linked $9.6M share sale headline overnight kills the AI-physician thesis.
25	DAVE	AVOID	1.8	1wk fc_mid -75%, fc_long -75% after a 114% run-up — this is the blowoff top.
26	SEZL	AVOID	1.6	Up 176% YTD, RSI 77.9, 1wk fc_mid -91%, targetUpside -19% — textbook top.
27	LCID	AVOID	1.5	18% layoffs and COO removal on July 2, gross margin -95.6%, operMargin -268%.
28	AMPG	AVOID	1.4	Weekly fc_long -62.6% after a 163% run-up; $180M cap and profitMargin -25%.
29	PGEN	AVOID	1.4	Every timeframe fc_mid and fc_long red (-24% to -67%); ROE -1145%, profitMargin -1213%.
30	TWST	AVOID	1.2	Up 222% YTD, RSI 77.75, targetUpside -18.3% — analyst PT hikes not enough to justify chase.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord